CKD-504

N/A

Report date: 2024/11/13 20:00:43
NME

Base Information

Drug NameCKD-504
Drug Alias NameDC-012CKD-504
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone deacetylase 6 inhibitors
TargetsHistone deacetylase 6
Therapy Area/IndicationsHuntington Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesChong Kun Dang Pharmaceutical Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChong Kun Dang Pharmaceutical Corp
Active IndicationsN/A
Inactive IndicationsHuntington Disease

Other Information

ATC CodeN/A
Related LinksN/A